CorneaGen raises $37M in Series B funding round


CorneaGen focuses on innovating technologies to cure corneal blindness by 2040 and provides donor tissues for cornea transplants.

Previous Blue Cross Blue Shield of Texas partnership to begin opening medical centers
Next Turning the Building Boom into a Vibrant, Lasting City